4//SEC Filing
Basso Stephen 4
Accession 0001209191-21-003594
CIK 0001693011other
Filed
Jan 13, 7:00 PM ET
Accepted
Jan 14, 4:15 PM ET
Size
5.6 KB
Accession
0001209191-21-003594
Insider Transaction Report
Form 4
Basso Stephen
Senior Vice President, Finance
Transactions
- Award
Stock Option (right to buy)
2021-01-13+41,794→ 41,794 totalExercise: $2.77Exp: 2030-04-22→ Common Stock (41,794 underlying)
Footnotes (1)
- [F1]This option was granted on April 23, 2020, with vesting subject to the satisfaction of performance based vesting criteria. The performance based vesting criteria were satisfied on January 13, 2021 and the shares underlying the option vest in equal monthly installments from April 23, 2020 through April 23, 2024.
Documents
Issuer
Inozyme Pharma, Inc.
CIK 0001693011
Entity typeother
Related Parties
1- filerCIK 0001815707
Filing Metadata
- Form type
- 4
- Filed
- Jan 13, 7:00 PM ET
- Accepted
- Jan 14, 4:15 PM ET
- Size
- 5.6 KB